AstraZeneca ordered to deliver 50mn Covid-19 vaccine doses or face fines

A Brussels court has ordered AstraZeneca to deliver an additional 50 million doses of Covid-19 vaccines to EU member states by September or face a maximum of 500 mn euros ($593 mn) in fines

AstraZeneca Covid-19 vaccine, AstraZeneca
AstraZeneca's Covid-19 vaccine | Photo: Bloomberg
IANS Brussels
2 min read Last Updated : Jun 19 2021 | 11:35 AM IST

A Brussels court has ordered AstraZeneca to deliver an additional 50 million doses of Covid-19 vaccines to European Union (EU) member states by September or face a maximum of 500 million euros ($593 million) in fines.

In a ruling on a legal case filed by the European Commission, the Court of First Instance of Brussels on Friday ordered the pharma giant to supply 15 million doses by July 26, 20 million by August 23, and 15 doses by September 27 in addition to the 30.2 million doses it had delivered as part of the original deal, reports Xinhua news agency.

In case of non-compliance with the deadlines, AstraZeneca will have to pay a penalty of 10 euros per dose not delivered.

The Court's decision is based on the fact that AstraZeneca committed a "serious breach" of its contractual obligations with the EU, the European Commission said in a statement.

European Commission President Ursula von der Leyen welcomed the decision, saying that the EU's vaccination program was built on a sound legal basis.

"This decision confirms the position of the Commission: AstraZeneca did not live up to the commitments it made in the contract. It is good to see that an independent judge confirms this," she said in a statement issued late Friday.

But even the pharma company claimed victory, saying the number of doses it was ordered to supply was far less than the 120 million vaccine doses cumulatively by the end of June 2021, and a total of 300 million doses by the end of September 2021 requested by the European Commission.

"To date, the Company has supplied more than 70 million doses to the EU and will substantially exceed 80.2 million doses by the end of June 2021," AstraZeneca said in a statement.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineAstraZenecaEuropean Union

First Published: Jun 19 2021 | 11:35 AM IST

Next Story